-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SlvzdI9Z8tfW4XHlv3pXDX3SPaXtSP3IXeWI/u8kw+XCPiBe+meAcA4xZKdOCXJ+ xHx0uDgZuaYcMgRG6AdqvA== 0001209191-09-022177.txt : 20090420 0001209191-09-022177.hdr.sgml : 20090420 20090420193736 ACCESSION NUMBER: 0001209191-09-022177 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090416 FILED AS OF DATE: 20090420 DATE AS OF CHANGE: 20090420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aviezer David CENTRAL INDEX KEY: 0001385112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33357 FILM NUMBER: 09760205 MAIL ADDRESS: STREET 1: C/O PROTALIX BIOTHERAPEUTICS, INC. STREET 2: 2 SNUNIT ST, SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Protalix BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001006281 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 650643773 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 BUSINESS PHONE: 972-4-988-9488 MAIL ADDRESS: STREET 1: 2 SNUNIT ST STREET 2: SCIENCE PARK, POB 455 CITY: CARMIEL STATE: L3 ZIP: 20100 FORMER COMPANY: FORMER CONFORMED NAME: ORTHODONTIX INC DATE OF NAME CHANGE: 19980422 FORMER COMPANY: FORMER CONFORMED NAME: EMBASSY ACQUISITION CORP DATE OF NAME CHANGE: 19960124 4 1 c84091_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2009-04-16 0001006281 Protalix BioTherapeutics, Inc. PLX 0001385112 Aviezer David C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455 CARMIEL L3 20100 ISRAEL 1 1 0 0 President & CEO Common Stock 2009-04-16 4 S 0 6700 2.50 D 0 I By Trust Common Stock 2009-04-17 4 S 0 10000 2.56 D 0 I By Trust Common Stock 2009-04-20 4 S 0 33300 2.51 D 0 I By Trust Common Stock 2009-04-20 4 M 0 52469 0.12 A 0 I By Trust Common Stock 2009-04-20 4 F 0 2469 2.55 D 0 I By Trust Stock Options (Right to Buy) 0.12 2009-04-20 4 M 0 52469 0 D 2013-12-08 Common Stock 52469 755389 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The reporting person acquired 50,000 shares of common stock upon the exercise of outstanding options, all of which shares were sold by the reporting person. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee upon the exercise of stock options must be registered in the name of a trustee. All of the options listed in Table II have vested. Does not include options to purchase 977,296 shares of common stock at an exercise price equal to $0.972 per share that expire on September 10, 2016, options to purchase 600,000 shares of common stock at an exercise price equal to $5.00 per share that expire on February 7, 2018, and options to purchase 100,000 shares of common stock at an exercise price equal to $2.65 that expire on February 25, 2019. /s/ Yossi Maimon 2009-04-20 -----END PRIVACY-ENHANCED MESSAGE-----